[1]Patent:EP1403255,2004,A1.Locationinpatent:Page75
[1]Patent:US2005/20623,2005,A1.Locationinpatent:Page116
[1]Patent:US2003/22905,2003,A1
2095410-88-9
1016167-99-9
1017356-25-0
1163729-53-0
1174020-26-8
1158750-00-5
1668553-26-1 | 7-(5-((4-(4-(N,N-Dimethylsulfamoyl)piperazin-1-yl)phenoxy)methyl)-1,3-dimethyl-1h-pyrazol-4-yl)-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1h-indole-2-carboxylic acid | AA0039TB | MFCD28399118
1206800-18-1 | 6-Bromo-1h-indazol-5-ol | AA0039XA | MFCD16877652
60889-33-0 | Hexahydro-1h-furo[3,4-c]pyrrole hydrochloride | AA003A1G | MFCD20527058
923288-90-8 | Nilotinib hcl monohydrate | AA003A50 | MFCD16038432
856847-77-3 | 3-Chloropyridazine, HCl | AA003A8B | MFCD12547058
82278-95-3 | 3-(3-Bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoic acid | AA003ACY | MFCD01317710
862170-55-6 | (4,6-Dichloropyridin-3-yl)(4-fluorophenyl)methanone | AA003AI7 | MFCD31543873
583052-21-5 | 2-(2,4-Difluorophenyl)-5-methylpyridine | AA003AO8 | MFCD17170319
797-63-7 | Levonorgestrel | AA003AUK | MFCD00199013
6770-38-3 | 1,4-Bis(methoxymethyl)benzene | AA003AXO | MFCD00025903